Skip to main content
. 2017 Aug 16;8(39):66491–66503. doi: 10.18632/oncotarget.20281

Figure 1. Identification of eligible randomized trials.

Figure 1

Abbreviations: EGFR, tyrosine kinase inhibitors; PD-1, programmed death-1; PD-L1, programmed death-ligand 1; TKI, tyrosine kinase inhibitors.